No accepted clinical therapies exist for repair of motor pathways following spinal cord injury (SCI) in humans, leaving permanent disability and devastating personal and socioeconomic cost. A robust neural repair strategy has been demonstrated in preclinical studies, that is ready for translation to recovery of hand and arm function in human SCI, comprising daily transcranial magnetic stimulation treatment at the inpatient rehabilitation facility. This study will establish clinical effect size of the intervention, as well as safety and feasibility necessary for a subsequent controlled efficacy trial and inform preclinical studies for dosing optimization.
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Eligibility - (Percentage candidates eligible of screened patients)
Timeframe: 21 months (Recruitment period)
Recruitment - (Percentage candidates enrolled of approached patients)
Timeframe: 21 months (Recruitment period)
Adherence to intervention - (Percentage candidates who dropout during the intervention period of enrolled candidates)
Timeframe: 2 years (Duration of human subjects' involvement)
Adherence to outcome assessment - (Percentage candidates who do not complete outcome assessments of enrolled candidates)
Timeframe: 2 years (Duration of human subjects' involvement)
Retention - (Percentage candidates who do not complete 6-month follow up of enrolled candidates)
Timeframe: 2 years (Duration of human subjects' involvement)
Adverse Events
Timeframe: 2 years (Duration of human subjects' involvement)